3.80
price down icon7.77%   -0.32
after-market Dopo l'orario di chiusura: 3.79 -0.010 -0.26%
loading
Precedente Chiudi:
$4.12
Aprire:
$3.91
Volume 24 ore:
369.59K
Relative Volume:
0.79
Capitalizzazione di mercato:
$37.52M
Reddito:
$2.05M
Utile/perdita netta:
$-23.15M
Rapporto P/E:
-0.573
EPS:
-6.6319
Flusso di cassa netto:
$-16.93M
1 W Prestazione:
-13.83%
1M Prestazione:
-40.72%
6M Prestazione:
+68.14%
1 anno Prestazione:
+29.25%
Intervallo 1D:
Value
$3.70
$3.95
Intervallo di 1 settimana:
Value
$3.70
$4.69
Portata 52W:
Value
$1.50
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Nome
iBio Inc
Name
Telefono
302-355-0650
Name
Indirizzo
600 Madison Avenue, Suite 1601, New York, NY
Name
Dipendente
54
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
IBIO's Discussions on Twitter

Confronta IBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IBIO
iBio Inc
3.80 37.52M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-28 Iniziato Chardan Capital Markets Buy
2021-11-29 Iniziato JMP Securities Mkt Outperform
2021-01-22 Iniziato Cantor Fitzgerald Overweight
2020-06-26 Iniziato Alliance Global Partners Buy

iBio Inc Borsa (IBIO) Ultime notizie

pulisher
Apr 01, 2025

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 01, 2025
pulisher
Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 21, 2025

iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World

Mar 19, 2025
pulisher
Mar 12, 2025

Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World

Mar 12, 2025
pulisher
Mar 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Mar 03, 2025
pulisher
Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025
pulisher
Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025
pulisher
Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025
pulisher
Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025
pulisher
Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025
pulisher
Feb 20, 2025

iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

iBio Inc. stock rises Wednesday, outperforms market - MarketWatch

Feb 19, 2025
pulisher
Feb 19, 2025

iBio Announces Transfer to Nasdaq Capital Market - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

Can iBio's Nasdaq Move Transform Its Market Presence? Key Details Revealed - StockTitan

Feb 19, 2025
pulisher
Feb 17, 2025

Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year? - Insider Monkey

Feb 17, 2025
pulisher
Feb 17, 2025

10 Stocks Insiders Are Buying This Year - Insider Monkey

Feb 17, 2025
pulisher
Feb 12, 2025

Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges - TipRanks

Feb 12, 2025
pulisher
Feb 11, 2025

iBio Inc. stock falls Tuesday, underperforms market - MarketWatch

Feb 11, 2025
pulisher
Feb 11, 2025

SEC Form 424B3 filed by iBio Inc. - Quantisnow

Feb 11, 2025
pulisher
Feb 10, 2025

iBio Inc. stock falls Monday, underperforms market - MarketWatch

Feb 10, 2025
pulisher
Feb 10, 2025

iBio Inc. (IBIO) reports earnings - Quartz

Feb 10, 2025
pulisher
Feb 10, 2025

iBio, Inc. Reports Second Quarter Fiscal 2025 Financial Results and Corporate Updates on Advancements in Cardiometabolic Therapeutics - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

iBio Reports Fiscal Second Quarter 2025 Financial Results - GlobeNewswire

Feb 10, 2025
pulisher
Feb 10, 2025

IBIO's Strategic Pivot: AI-Powered Antibody Discovery Shows Promise Despite Q2 Losses - StockTitan

Feb 10, 2025
pulisher
Feb 07, 2025

A Tale of Resilience: iBio Inc Amid Stock Market Turbulence - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

iBio (IBIO) Projected to Post Quarterly Earnings on Friday - Defense World

Feb 07, 2025
pulisher
Feb 04, 2025

iBio (NYSE:IBIO) Trading Up 4% – Time to Buy? - Defense World

Feb 04, 2025
pulisher
Feb 04, 2025

iBio (NYSEMKT:IBIO) Trading Up 1.3% – Still a Buy? - Defense World

Feb 04, 2025

iBio Inc Azioni (IBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):